Bio-Connect

Goat anti-Neuropeptide Y receptor Y5

EB06769
Everest Biotech
ApplicationsImmunoPrecipitation, Western Blot, ELISA, ImmunoHistoChemistry
Product group Antibodies
TargetNPY5R
100 ug
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Everest Biotech
  • Product Name
    Goat anti-Neuropeptide Y receptor Y5 Antibody
  • Delivery Days Customer
    5
  • Application Supplier Note
    Immunoprecipitation: Customer feedback showed specific results when this product was used in IP. This antibody has been successfully used in IP: PMID: 30503694.
  • Applications
    ImmunoPrecipitation, Western Blot, ELISA, ImmunoHistoChemistry
  • Applications Supplier
    Pep-ELISA, WB, IP, IHC
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.5 mg/ml
  • Gene ID4889
  • Target name
    NPY5R
  • Target description
    neuropeptide Y receptor Y5
  • Target synonyms
    NPY5-R, NPYR5, NPYY5-R, neuropeptide Y receptor type 5, NPY-Y5 receptor, Y5 receptor
  • Host
    Goat
  • Scientific Description
    RefSeq number(s): NP_006165.1. GeneIDs all Nonhuman: 18168 (mouse); 25340 (rat);. Purification: Antigen affinity purified. Names and symbols: neuropeptide Y receptor Y5 ; HGNC:7958; NPY5R; NPYR5
  • Reactivity Supplier
    Human, Mouse, Rat, Dog
  • Storage Instruction
    -20°C
  • UNSPSC
    12352203

References

  • Czarnecka M, Lu C, Pons J, et al. Neuropeptide Y receptor interactions regulate its mitogenic activity. Neuropeptides. 2019,73:11-24. doi: 10.1016/j.npep.2018.11.008
    Read this paper
  • Czarnecka M, Kitlinska J. Cell Surface Protein Detection to Assess Receptor Internalization. Bio Protoc. 2016,6(20):pii: e1968. doi: 10.21769/BioProtoc.1968.
    Read this paper
  • Sheriff S, Ali M, Yahya A, et al. Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line. Mol Cancer Res. 2010,8(4):604-14. doi: 10.1158/1541-7786.MCR-09-0301
    Read this paper